Tech Company Financing Transactions

Arvinas Funding Round

On 4/5/2018, Arvinas raised $55 million in Series C funding from Nextech Invest, 5AM Ventures and Canaan Partners.

Transaction Overview

Company Name
Arvinas
Announced On
4/5/2018
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors

Nextech Invest (Lead Investor) (Jakob Loven)

5AM Ventures (Richard Ulevitch)

Canaan Partners (Timothy Shannon)

Deerfield Capital

Hillhouse Capital Group

New Leaf Venture Partners

OrbiMed (Stephen Squinto)

RA Capital (Andrew Levin)

Sirona Capital

Proceeds Purpose
Proceeds from the financing will support the advancement of the Company's two lead programs toward clinical investigation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5 Science Park 395 Winchester Ave.
New Haven, CT 06511
USA
Phone
(203) 535-1456
Website
www.arvinas.com
Email Address
[email protected]
Overview
Arvinas is a pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases.
Profile
Arvinas LinkedIn Company Profile
Social Media
Arvinas Company Twitter Account
Company News
Arvinas News
Facebook
Arvinas on Facebook
YouTube
Arvinas on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Houston
  John Houston LinkedIn Profile  John Houston Twitter Account  John Houston News  John Houston on Facebook
Chief Financial Officer
Sean Cassidy
  Sean Cassidy LinkedIn Profile  Sean Cassidy Twitter Account  Sean Cassidy News  Sean Cassidy on Facebook
Chief Scientific Officer
Ian Taylor
  Ian Taylor LinkedIn Profile  Ian Taylor Twitter Account  Ian Taylor News  Ian Taylor on Facebook
Chief Technical Officer
Andrew Crew
  Andrew Crew LinkedIn Profile  Andrew Crew Twitter Account  Andrew Crew News  Andrew Crew on Facebook
Vice President
Angela Cacace
  Angela Cacace LinkedIn Profile  Angela Cacace Twitter Account  Angela Cacace News  Angela Cacace on Facebook
Vice President
Kimberly Wehger
  Kimberly Wehger LinkedIn Profile  Kimberly Wehger Twitter Account  Kimberly Wehger News  Kimberly Wehger on Facebook
VP - Bus. Development
Matthew Batters
  Matthew Batters LinkedIn Profile  Matthew Batters Twitter Account  Matthew Batters News  Matthew Batters on Facebook
VP - Bus. Development
Randy Teel
  Randy Teel LinkedIn Profile  Randy Teel Twitter Account  Randy Teel News  Randy Teel on Facebook
VP - Human Resources
Steve Weiss
  Steve Weiss LinkedIn Profile  Steve Weiss Twitter Account  Steve Weiss News  Steve Weiss on Facebook
VP - Manufacturing
John Grosso
  John Grosso LinkedIn Profile  John Grosso Twitter Account  John Grosso News  John Grosso on Facebook
VP - Operations
Marcia Moore
  Marcia Moore LinkedIn Profile  Marcia Moore Twitter Account  Marcia Moore News  Marcia Moore on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/5/2018: Chairman Mom venture capital transaction
Next: 4/5/2018: Coveo venture capital transaction

 

Share this article

 

Where The Data Comes From

We record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.